TITAN PHARMACEUTICALS INC DE (TTNP)
Institutional ownership reported to the SEC as of Q2 2026, across 31 quarters.
5
Reporting holders
$69
Reported value
0.0%
Held as options
-1
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| CoreCap Advisors, LLC | $65 | 88 | 0.00% | 6q | HELD |
| CALDWELL SUTTER CAPITAL, INC. | $1 | 1 | 0.00% | 11q | HELD |
| ST GERMAIN D J CO INC | $1 | 1 | 0.00% | 10q | HELD |
| Bogart Wealth, LLC | $1 | 1 | 0.00% | 2q | HELD |
| Farther Finance Advisors, LLC | $1 | 1 | 0.00% | 2q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 5 | $69 | 92 | 0 | 0 | 0 | 0.0% |
| Q1 2026 | 6 | $130 | 94 | 2 | 0 | 0 | 0.0% |
| Q4 2025 | 4 | $154 | 92 | 0 | 0 | 0 | 0.0% |
| Q3 2025 | 17 | $107.1K | 22,362 | 2 | 1 | 1 | 0.0% |
| Q2 2025 | 20 | $158.3K | 37,686 | 3 | 2 | 2 | 0.0% |
| Q1 2025 | 17 | $51.9K | 14,708 | 3 | 2 | 1 | 0.0% |
| Q4 2024 | 15 | $9.4K | 2,889 | 0 | 1 | 2 | 0.0% |
| Q3 2024 | 16 | $88.5K | 16,799 | 1 | 3 | 0 | 0.0% |
| Q2 2024 | 18 | $179.3K | 32,191 | 1 | 2 | 2 | 0.0% |
| Q1 2024 | 17 | $230.0K | 32,125 | 15 | 0 | 1 | 0.0% |
| Q4 2023 | 22 | $352.3K | 871,605 | 3 | 2 | 5 | 0.0% |
| Q3 2023 | 23 | $433.9K | 918,703 | 4 | 4 | 1 | 0.0% |
| Q2 2023 | 22 | $544.7K | 842,533 | 4 | 1 | 3 | 0.0% |
| Q1 2023 | 19 | $683.5K | 812,833 | 1 | 4 | 1 | 1.3% |
| Q4 2022 | 18 | $603.4K | 747,862 | 9 | 0 | 1 | 2.9% |
| Q3 2022 | 15 | $1.2M | 1,054,021 | 5 | 2 | 4 | 3.8% |
| Q2 2022 | 14 | $380.0K | 664,541 | 4 | 5 | 1 | 1.6% |
| Q1 2022 | 13 | $1.3M | 1,297,707 | 4 | 3 | 2 | 1.0% |
| Q4 2021 | 12 | $629.0K | 457,504 | 5 | 2 | 1 | 25.3% |
| Q3 2021 | 11 | $815.0K | 386,504 | 2 | 1 | 4 | 11.5% |
| Q2 2021 | 14 | $2.2M | 580,876 | 4 | 3 | 3 | 30.7% |
| Q1 2021 | 14 | $2.7M | 332,131 | 7 | 3 | 2 | 63.8% |
| Q4 2020 | 11 | $1.2M | 137,621 | 13 | 0 | 0 | 60.9% |
| Q3 2020 | 11 | $1.2M | 6,934,796 | 1 | 1 | 1 | 3.1% |
| Q2 2020 | 18 | $883.2K | 2,607,331 | 9 | 3 | 2 | 9.5% |
| Q1 2020 | 13 | $725.1K | 2,834,151 | 3 | 7 | 1 | 9.0% |
| Q4 2019 | 16 | $408.1K | 2,000,036 | 7 | 3 | 2 | 5.1% |
| Q3 2019 | 13 | $284.1K | 806,440 | 3 | 1 | 5 | 23.9% |
| Q2 2019 | 17 | $2.6M | 970,858 | 2 | 4 | 2 | 51.9% |
| Q1 2019 | 17 | $2.0M | 696,140 | 15 | 0 | 2 | 39.5% |
| Q4 2018 | 24 | $1.0M | 4,543,310 | 2 | 1 | 1 | 0.4% |